NOVAVAX INC (NVAX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch NVAX
See up to 3 months of NVAX. The 7-day demo opens the 1M and 3M ranges and puts NVAX on your watchlist.
Start 7-day demoLatest NVAX insider trades
About NOVAVAX INC (NVAX)
NOVAVAX INC is an SEC registrant, filing under CIK 0001000694, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
NVAX Form 4 activity by transaction type, last 90 days
No Form 4 activity for NVAX in the last 90 days.
NVAX insider transactions (Form 4)
9343 Form 4 filings on record, the earliest from Nov 13, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Richard J. Rodgers - Director | Option exercise | Restricted Stock Units | 18,880 | $0.00 | - | |
| Richard J. Rodgers - Director | Option exercise | Common Stock | 18,880 | - footnote F1 | - | |
| Richard J. Rodgers - Director | Grant or award | Stock Option (Right to Buy) | 21,270 | $0.00 | - | |
| Richard J. Rodgers - Director | Grant or award | Restricted Stock Units | 14,180 | $0.00 | - | |
| ||||||
| Rachel K. King - Director | Option exercise | Restricted Stock Units | 18,880 | $0.00 | - | |
| Rachel K. King - Director | Option exercise | Common Stock | 18,880 | - footnote F1 | - | |
| Rachel K. King - Director | Grant or award | Stock Option (Right to Buy) | 21,270 | $0.00 | - | |
| Rachel K. King - Director | Grant or award | Restricted Stock Units | 14,180 | $0.00 | - | |
| ||||||
 Richard Douglas - Director | Grant or award | Restricted Stock Units | 14,180 | $0.00 | - | |
| Richard Douglas - Director | Option exercise | Restricted Stock Units | 18,880 | $0.00 | - | |
| Richard Douglas - Director | Option exercise | Common Stock | 18,880 | - footnote F1 | - | |
| Richard Douglas - Director | Grant or award | Stock Option (Right to Buy) | 21,270 | $0.00 | - | |
| ||||||
| Margaret G. McGlynn - Director | Grant or award | Stock Option (Right to Buy) | 21,270 | $0.00 | - | |
| Margaret G. McGlynn - Director | Grant or award | Restricted Stock Units | 14,180 | $0.00 | - | |
| Margaret G. McGlynn - Director | Option exercise | Restricted Stock Units | 18,880 | $0.00 | - | |
| Margaret G. McGlynn - Director | Option exercise | Common Stock | 18,880 | - footnote F1 | - | |
| ||||||
 David M. Mott - Director | Option exercise | Common Stock | 18,880 | - footnote F1 | - | |
| David M. Mott - Director | Grant or award | Stock Option (Right to Buy) | 21,270 | $0.00 | - | |
| David M. Mott - Director | Grant or award | Restricted Stock Units | 14,180 | $0.00 | - | |
| David M. Mott - Director | Option exercise | Restricted Stock Units | 18,880 | $0.00 | - | |
| ||||||
| Gregg H. Alton - Director | Grant or award | Restricted Stock Units | 14,180 | $0.00 | - | |
| Gregg H. Alton - Director | Option exercise | Restricted Stock Units | 18,880 | $0.00 | - | |
| Gregg H. Alton - Director | Option exercise | Common Stock | 18,880 | - footnote F1 | - | |
| Gregg H. Alton - Director | Grant or award | Stock Option (Right to Buy) | 21,270 | $0.00 | - | |
| ||||||
| John W. Shiver - Director | Grant or award | Restricted Stock Units | 14,180 | $0.00 | - | |
| John W. Shiver - Director | Grant or award | Stock Option (Right to Buy) | 21,270 | $0.00 | - | |
| Charles W. Newton - Director | Grant or award | Stock Option (Right to Buy) | 21,270 | $0.00 | - | |
| Charles W. Newton - Director | Grant or award | Restricted Stock Units | 14,180 | $0.00 | - | |
| Charles W. Newton - Director | Option exercise | Common Stock | 9,520 | $0.00 | - | |
| Charles W. Newton - Director | Option exercise | Restricted Stock Units | 9,520 | $0.00 | - | |
 Robert Edward Walker - Officer | Grant or award | Stock Option (Right to Buy) | 99,500 | $0.00 | - | |
| Robert Edward Walker - Officer | Grant or award | Restricted Stock Units | 66,000 | $0.00 | - | |
| John W. Shiver - Director | Option exercise | Common Stock | 7,947 | $0.00 | - | |
| John W. Shiver - Director | Option exercise | Restricted Stock Units | 7,947 | $0.00 | - | |
| James Patrick Kelly - Officer | Option exercise | Common Stock | 12,223 | $0.00 | - | |
| James Patrick Kelly - Officer | Tax withholding / forfeiture | Common Stock | 5,904 footnote F1 | $9.98 | $59K | |
| James Patrick Kelly - Officer | Option exercise | Restricted Stock Units | 12,223 | $0.00 | - | |
| ||||||
| Ruxandra Draghia-Akli - Officer | Grant or award | Non-Statutory Stock Option NQ | 139,500 | $0.00 | - | |
| Mark J. Casey - Officer | Grant or award | Non-Statutory Stock Option NQ | 152,000 | $0.00 | - | |
 John C. Jacobs - Officer | Grant or award | Non-Statutory Stock Option NQ | 551,500 | $0.00 | - | |
 Elaine O'Hara - Officer | Grant or award | 2026 Non-statutory Stock Option NQ | 177,500 | $0.00 | - | |
| James Patrick Kelly - Officer | Option exercise | Common Stock | 43,167 | $0.00 | - | |
| James Patrick Kelly - Officer | Tax withholding / forfeiture | Common Stock | 20,850 footnote F1 | $9.49 | $198K | |
| James Patrick Kelly - Officer | Option exercise | Restricted Stock Units | 43,167 | $0.00 | - | |
| ||||||
| John C. Jacobs - Officer | Option exercise | Common Stock | 150,167 | $0.00 | - | |
| John C. Jacobs - Officer | Tax withholding / forfeiture | Common Stock | 69,288 footnote F1 | $9.49 | $658K | |
| John C. Jacobs - Officer | Option exercise | Restricted Stock Units | 150,167 | $0.00 | - | |
| ||||||
| Elaine O'Hara - Officer | Option exercise | Common Stock | 56,334 | $0.00 | - | |
| Elaine O'Hara - Officer | Tax withholding / forfeiture | Common Stock | 22,429 footnote F1 | $9.49 | $213K | |
| Elaine O'Hara - Officer | Option exercise | Restricted Stock Units | 56,334 | $0.00 | - | |
| ||||||
| Mark J. Casey - Officer | Option exercise | Common Stock | 37,500 | $0.00 | - | |
| Mark J. Casey - Officer | Tax withholding / forfeiture | Common Stock | 11,378 footnote F1 | $9.49 | $108K | |
| Mark J. Casey - Officer | Option exercise | Restricted Stock Units | 4,000 | $0.00 | - | |
| ||||||
| Ruxandra Draghia-Akli - Officer | Tax withholding / forfeiture | Common Stock | 11,313 footnote F1 | $9.49 | $107K | |
| Ruxandra Draghia-Akli - Officer | Grant or award | Restricted Stock Units | 93,000 | $0.00 | - | |
| Ruxandra Draghia-Akli - Officer | Grant or award | Non-Statutory Stock Opotion NQ | 139,500 | $9.09 | $1.27M | |
| Ruxandra Draghia-Akli - Officer | Derivative | Restricted Stock Units | 26,667 | $0.00 | - | |
| Ruxandra Draghia-Akli - Officer | Option exercise | Common Stock | 26,667 | $0.00 | - | |
| ||||||
| John C. Jacobs - Officer | Option exercise | Common Stock | 83,333 | $0.00 | - | |
| John C. Jacobs - Officer | Tax withholding / forfeiture | Common Stock | 38,450 footnote F1 | $10.14 | $390K | |
| John C. Jacobs - Officer | Option exercise | Restricted Stock Units | 83,333 | $0.00 | - | |
| John C. Jacobs - Officer | Grant or award | Restricted Stock Units | 367,500 | $0.00 | - | |
| John C. Jacobs - Officer | Grant or award | Non-Statutory Stock Option NQ | 551,500 | $9.09 | $5.01M | |
| ||||||
| James Patrick Kelly - Officer | Tax withholding / forfeiture | Common Stock | 28,366 footnote F1 | $10.14 | $288K | |
| James Patrick Kelly - Officer | Derivative | Restricted Stock Units | 58,666 | $0.00 | - | |
| James Patrick Kelly - Officer | Grant or award | Restricted Stock Units | 129,500 | $0.00 | - | |
| James Patrick Kelly - Officer | Grant or award | Non-statutory Stock Option NQ | 194,000 | $9.09 | $1.76M | |
| James Patrick Kelly - Officer | Option exercise | Common Stock | 58,666 | $0.00 | - | |
| ||||||
| Elaine O'Hara - Officer | Tax withholding / forfeiture | Common Stock | 5,375 footnote F1 | $10.14 | $55K | |
| Elaine O'Hara - Officer | Grant or award | Restricted Stock Units | 118,000 | $0.00 | - | |
| Elaine O'Hara - Officer | Grant or award | 2026 Non-statutory Stock Option NQ | 177,500 | $9.09 | $1.61M | |
| Elaine O'Hara - Officer | Option exercise | Common Stock | 19,600 | $0.00 | - | |
| Elaine O'Hara - Officer | Option exercise | Common Stock | 40,000 | $0.00 | - | |
| Elaine O'Hara - Officer | Tax withholding / forfeiture | Common Stock | 10,969 footnote F1 | $10.14 | $111K | |
| Elaine O'Hara - Officer | Option exercise | Restricted Stock Units | 19,600 | $0.00 | - | |
| Elaine O'Hara - Officer | Option exercise | Restricted Stock Units | 40,000 | $0.00 | - | |
| ||||||
| Mark J. Casey - Officer | Grant or award | Restricted Stock Units | 101,000 | $0.00 | - | |
| Mark J. Casey - Officer | Grant or award | Non-Statutory Stock Opotion NQ | 152,000 | $9.09 | $1.38M | |
| Mark J. Casey - Officer | Option exercise | Common Stock | 4,000 | $0.00 | - | |
| Mark J. Casey - Officer | Tax withholding / forfeiture | Common Stock | 1,214 footnote F1 | $10.14 | $12K | |
| Mark J. Casey - Officer | Option exercise | Restricted Stock Units | 4,000 | $0.00 | - | |
| ||||||
| John C. Jacobs - Officer | Option exercise | Common Stock | 83,197 | $0.00 | - | |
| John C. Jacobs - Officer | Tax withholding / forfeiture | Common Stock | 39,132 | $9.17 | $359K | |
| John C. Jacobs - Officer | Option exercise | Restricted Stock Units | 83,197 | $0.00 | - | |
| Ruxandra Draghia-Akli - Officer | Option exercise | Common Stock | 14,257 | $0.00 | - | |
| Ruxandra Draghia-Akli - Officer | Tax withholding / forfeiture | Common Stock | 6,048 | $7.40 | $45K | |
| Ruxandra Draghia-Akli - Officer | Derivative | Restricted Stock Units | 14,257 | $0.00 | - | |
| Richard J. Rodgers - Director | Option exercise | Common Stock | 3,800 | - footnote F1 | - | |
| Richard J. Rodgers - Director | Option exercise | Restricted Stock Units | 3,800 | $0.00 | - | |
| ||||||
| Richard J. Rodgers - Director | Grant or award | Stock Option (Right to Buy) | 28,326 | $6.42 | $182K | |
| Richard J. Rodgers - Director | Grant or award | Restricted Stock Units | 18,884 | $0.00 | - | |
| David M. Mott - Director | Grant or award | Stock Option (Right to Buy) | 28,326 | $6.42 | $182K | |
| David M. Mott - Director | Grant or award | Restricted Stock Units | 18,884 | $0.00 | - | |
Item 2.02, 9.01
Item 5.07
Item 2.02, 9.01
Item 2.02, 9.01
Recent NVAX Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
NVAX insider trading FAQ
What is the latest insider trade for NVAX?
NOVAVAX INC (NVAX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-23. The full record for NVAX runs to 43 Form 4 filings, the earliest from 2024-11-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NVAX stock?
No insider purchases of NVAX were filed in the last 90 days.
How many insiders are selling NVAX stock?
No insider sales of NVAX were filed in the last 90 days.
Where can I see NVAX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NVAX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Richard J. Rodgers view on EDGAR
- - Rachel K. King view on EDGAR
- - Richard Douglas view on EDGAR
- - Margaret G. McGlynn view on EDGAR
- - David M. Mott view on EDGAR
- - Gregg H. Alton view on EDGAR
- - John W. Shiver view on EDGAR
- - Charles W. Newton view on EDGAR
- - Charles W. Newton view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NVAX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NVAX with a 7-day demo
- NVAX on your watchlist
- Every NVAX Form 4 filing on record
- Up to 3 months of NVAX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
